KCNMA1 and pachyonychia congenita: Recent findings suggested that KCa1.1 in LNCaP spheroids, which mimic human prostate cancer (PC) stem cells, has the potential to be a therapeutic target for overcoming anti-androgen and doxorubicin resistance in PC cells (123).